Search by Drug Name or NDC

    NDC 71773-0100-12 Xerava 100 mg/1 Details

    Xerava 100 mg/1

    Xerava is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Tetraphase Pharmaceuticals, Inc.. The primary component is ERAVACYCLINE DIHYDROCHLORIDE.

    Product Information

    NDC 71773-0100
    Product ID 71773-100_6dae690a-73ae-42d2-a340-0d1c1f47fc13
    Associated GPIs 04300030102140
    GCN Sequence Number 081518
    GCN Sequence Number Description eravacycline di-hydrochloride VIAL 100 MG INTRAVEN
    HIC3 W1C
    HIC3 Description TETRACYCLINE ANTIBIOTICS
    GCN 48656
    HICL Sequence Number 045183
    HICL Sequence Number Description ERAVACYCLINE DI-HYDROCHLORIDE
    Brand/Generic Brand
    Proprietary Name Xerava
    Proprietary Name Suffix n/a
    Non-Proprietary Name eravacycline
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 100
    Active Ingredient Units mg/1
    Substance Name ERAVACYCLINE DIHYDROCHLORIDE
    Labeler Name Tetraphase Pharmaceuticals, Inc.
    Pharmaceutical Class Tetracycline-class Antibacterial [EPC], Tetracyclines [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA211109
    Listing Certified Through 2024-12-31

    Package

    NDC 71773-0100-12 (71773010012)

    NDC Package Code 71773-100-12
    Billing NDC 71773010012
    Package 12 CARTON in 1 PACKAGE (71773-100-12) / 1 VIAL, GLASS in 1 CARTON (71773-100-05) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS
    Marketing Start Date 2020-09-14
    NDC Exclude Flag N
    Pricing Information N/A